Gluten Intolerance Treatment Market to Hit US$ 1,983.35 Million by 2031 | Exclusive Report by Growth Plus Reports


Newark, New Castle, USA, June 07, 2023 (GLOBE NEWSWIRE) — The market analysis of the global gluten intolerance treatment market was conducted by Growth Plus Reports in 2022 and valued at US$ 659.70 million. The market is expected to hit a revenue CAGR of 13.01% to reach US$ 1,983.35 million by 2031.

Analysis of the global market for gluten intolerance treatment indicates that during the forecast period, revenue share is likely to increase significantly. Wheat, barley, rye, and other grains all contain the natural protein known as gluten. It may be discovered in common meals and drinks such as pasta, cereal, and beer. 

Get a Sample Copy of the Research Report:


                            Gluten Intolerance Treatment Market Scope

Report Attribute Details
Market Size Value in 2022 US$ 659.70 million
Revenue Forecast in 2031 US$ 1,983.35 million
CAGR 13.01%
Base Year for Estimation 2022
Forecast Period 2023 to 2031
Historical Year 2021
Segments Covered Type, Drug Type, and Region
Regional Scope North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

The gluten intolerance treatment market refers to the industry involved in providing products and services to individuals who are intolerant to gluten. Gluten intolerance encompasses various conditions, such as celiac disease and non-celiac gluten sensitivity, where the consumption of gluten triggers adverse reactions in the body.

The gluten intolerance treatment market has been experiencing a significant rise in revenue driven by several factors. Rising awareness about gluten-related disorders, such as celiac disease and non-celiac gluten sensitivity, among both patients and healthcare professionals has led to increased diagnosis and demand for effective treatment options. The market revenue is also influenced by the growing adoption of gluten-free diets as a lifestyle choice among individuals without diagnosed disorders. 

This trend has propelled the demand for gluten-free food products, supplements, and medications. Moreover, advancements in medical research and the development of innovative therapeutics, including enzyme-based treatments and potential immunotherapies, are expanding the treatment landscape for gluten intolerance. The market is further supported by favorable government regulations promoting the availability and labeling of gluten-free products. 

However, challenges remain, including the high cost of specialized gluten-free products and the need for improved diagnostic methods, creating opportunities for companies to invest in research and development activities to address these concerns and capture a larger share of the market.

Request for Customization –

Recent Development in the Gluten Intolerance Treatment Market: 

  • In May 2023, Anokion SA announced favorable new pharmacodynamic and pharmacokinetic data from the company’s completed Phase 1 clinical trial evaluating KAN-101 as a treatment for celiac disease. KAN-101 is a novel liver-targeted therapy for celiac disease.

Competitive Landscape

A list of the prominent players operating in the global market for gluten intolerance treatment includes: 

  • Alvine Pharmaceuticals
  • ImmusanT
  • Artielle
  • Funzyme Biotechnologies
  • Innovate Biopharma
  • AMYRA Biotech AG

Market Segmentation: 

Based on type, the global gluten intolerance treatment market is segmented into celiac diseases, dermatitis herpetiform, and gluten ataxia. 

Based on drug type, the global gluten intolerance treatment market is segmented into antihistamines, epinephrine, and others. 

Celiac disease registered for prominent revenue shares in the global gluten intolerance treatment market in 2022, majorly attributed to a large patient pool.

North America dominates the global market while accounting for the largest revenue share. The market dominance in this region is majorly attributed to the high prevalence of gluten intolerance treatment among people. 

Table of Content

    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022) 
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
    1. Celiac Disease
    2. Dermatitis Herpetiform
    3. Gluten Ataxia
    1. Antihistamine
    2. Epinephrine
    3. Others


Buy this Premium Research Report:


  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market.


  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • ‘Business Profile’ of Key Players

Schedule a call with our analyst:

Visit our report store at –

Browse more latest healthcare reports:

Nummular Eczema Treatment Market by Drug Class (Immunomodulators, Antibiotics, Antihistamines), Route of Administration (Topical, Oral, Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Global Outlook & Forecast 2023-2031

Mirvetuximab Soravtansine Market by Indication (Ovarian Cancer, Fallopian Tube Carcinoma), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Marine Nutraceuticals Market by Product (Omega-3 Fatty Acids, Fucoidan, Seaweeds), Application (Dietary Supplements, Pharmaceuticals), Form (Softgel Capsules, Powders, Liquid), Distribution Channel (Hypermarkets, Specialty Retail Stores) – Global Outlook & Forecast 2023-2031

Adenosquamous Carcinoma Treatment Market by Indication (Breast Cancer, Lungs Cancer), Treatment Regime (Monotherapy, Combination Therapy), Therapy (Chemotherapy, Immunotherapy) – Global Outlook & Forecast 2023-2031

Adenosine Deaminase Inhibitors Market by Type (Pentostatin, Elapegademase), Application (Chronic Lymphocytic Leukemia, Hairy Cell Leukemia) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020”.

CONTACT: Manan Sethi Director, Market Insights Email: [email protected] 256 Chapman Road STE 105-4, Newark, New Castle - 19702, USA Phone no: +1 888 550 5009 Web:

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.